{
  "meta": {
    "title": "Pyq_Mini_Test_2_-_Physiology",
    "url": "https://brainandscalpel.vercel.app/pyq-mini-test-2-physiology-a1b54e7d.html",
    "scrapedAt": "2025-11-30T07:33:50.069Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Rapid x descent</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Absent a wave</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Cannon a wave</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Rapid y descent</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old woman presents with palpitations and lightheadedness. On examination, her pulse is irregularly irregular with a heart rate of 150 beats per minute. Auscultation reveals a loud P2 but no murmurs. What is the most likely finding on her jugular venous pulse (JVP) examination?</span></p>",
      "unique_key": "Q314443",
      "question_audio": null,
      "question_video": null,
      "map_id": 314443,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>In atrial fibrillation, ineffective atrial contractions lead to absence of a wave in the jugular venous pulse.</p><ul><li>This patient's irregularly irregular rhythm and high heart rate (150 bpm) are classic for atrial fibrillation (AF), the most common sustained arrhythmia.</li><li>AF is characterized by disorganized atrial electrical activity, resulting in the absence of coordinated atrial contraction.</li><li>Since the right atrium does not contract effectively, the 'a' wave which represents right atrial contraction against a closed tricuspid valve is absent in the JVP waveform.</li><li>Additional Features of Atrial Fibrillation:<ul><li>Mechanism: Multiple re-entrant circuits and ectopic atrial activity override SA node pacing</li><li>Pulse: Irregularly irregular, varying pulse volume</li><li>ECG Findings:<ul><li>Absent P waves</li><li>Irregularly irregular R-R intervals</li><li>Fibrillatory baseline waves (especially in lead V1)</li></ul></li><li>Heart Rate: Often rapid initially (120-160 bpm), slows down with rate control</li><li>Heart Sounds: May have variable S1 intensity, but no murmurs unless structural heart disease is present</li><li>Auscultation finding in this patient: Loud P2 may suggest pulmonary hypertension as a consequence of AF or underlying mitral valve disease</li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/RecallGTPII22072025/129E.png\"><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/RecallGTPII22072025/129E1.png\"><p><strong>Reference:</strong> <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271481/\" target=\"_blank\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271481/</a></p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Acrosome reaction</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Cortical reaction</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Zona reaction</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Capacitation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following mechanisms plays a key role in preventing polyspermy?</span></p>",
      "unique_key": "Q314444",
      "question_audio": null,
      "question_video": null,
      "map_id": 314444,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000000
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li><strong>Cortical reaction:</strong> After the sperm enters the egg, cortical granules in the egg release enzymes that modify the zona pellucida, preventing further sperm from binding and entering the egg, thus preventing polyspermy.</li></ul><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizSep2025/PYQPhysioII29092025/2E.png\"><p><strong>Explanation for other options:</strong></p><p><strong>Acrosome reaction (Option A):</strong> It helps the sperm penetrate the egg, not prevent polyspermy.</p><p><strong>Zona reaction (Option C): </strong>Although it helps block other sperm after one has entered, the cortical reaction is the main process preventing polyspermy.</p><p><strong>Capacitation (Option D):</strong> It enables sperm to fertilise the egg but does not directly prevent polyspermy.</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Quinidine</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrhythmia refers to an abnormality in the heart's rhythm. Effective and timely treatment is essential. One therapeutic approach involves modulation or blockade of specific ion channels. Prolongation of refractoriness in cardiac tissue is primarily achieved through the modulation of which ion channel?</span></p>",
      "unique_key": "Q314445",
      "question_audio": null,
      "question_video": null,
      "map_id": 314445,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>Amiodarone</strong> is a drug that prolongs the refractoriness of K+ channels. Thus <strong>depresses the ectopic activity</strong> and reduces the discrepancy between normal and reentry path. <strong>Sotalol and dofetilide </strong>have similar actions.</p><p><strong>Explanation for other options:</strong></p><p><strong>Quinidine (Option A)</strong>: It can slow down INa with minimal prolongation of refractoriness.</p><p><strong>Nifedipine and diltiazem</strong> <strong>(Option C and D): </strong>These are calcium channel blocker drugs. They block L-type voltage-gated Ca2+ channels that can slow SA pacemaker and AV conduction.</p><p><strong>For information:</strong> drugs that block &beta;-adrenergic receptors, thus reducing the activation of ICaL, are propranolol, metoprolol.</p><p><strong>Key Takeaway:</strong></p><p><strong>Side effects of Amiodarone -</strong></p><ul><li><strong>System Affected are:</strong><ul><li>Pulmonary</li><li>Endocrine</li><li>Hepatic</li><li>Ocular</li><li>Cutaneous</li></ul></li><li><strong>Adverse Effect:</strong><ul><li>Pulmonary - Pulmonary fibrosis, interstitial pneumonitis</li><li>Endocrine - Hypothyroidism or hyperthyroidism (due to high iodine content)</li><li>Hepatic - Hepatotoxicity: elevated liver enzymes, jaundice, fatigue</li><li>Ocular - Corneal microdeposits, blurred vision, halos around lights</li><li>Cutaneous - Photosensitivity, blue-grey skin discolouration (especially on sun-exposed areas)</li></ul></li></ul>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Blocks adenosine action and causes wakefulness</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Activates the locus coeruleus and causes wakefulness</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">No role in maintaining wakefulness if taken 1 hour before sleep</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Activates histamine release and prevents sleep</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Caffeine impairs sleep by which of the following:</span></p>",
      "unique_key": "Q314446",
      "question_audio": null,
      "question_video": null,
      "map_id": 314446,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Caffeine works by blocking adenosine receptors.</p><ul><li>Adenosine is a neurotransmitter that promotes sleep by slowing down nerve activity. By blocking adenosine, caffeine prevents the brain from sensing sleepiness, thereby promoting wakefulness.</li></ul><p><strong>Explanation for other options:</strong></p><p><strong>Activates locus coeruleus and causes wakefulness (Option B): </strong>The locus coeruleus is a nucleus in the brainstem involved in arousal and wakefulness. While it does play a role in promoting wakefulness, caffeine's primary mechanism of action is not through direct activation of the locus coeruleus.</p><p><strong>No role in maintaining wakefulness if taken 1 hour before sleep (Option C): </strong>Caffeine is well-known for its role in maintaining wakefulness by counteracting sleep-promoting mechanisms in the brain.</p><p><strong>Activates histamine release and prevents sleep (Option D): </strong>Histamine is involved in promoting wakefulness, but caffeine does not directly cause histamine release. Its effect on sleep is primarily through adenosine receptor blockade rather than histamine pathways.</p><p><strong>Key Takeaway:</strong></p><h4><strong>Metabolic Theory</strong></h4><p>There are 2 centres located in the hypothalamus, which are in constant mutual inhibition.</p><ul><li><strong>Wake-Promoting Area:</strong> Located in the posterior hypothalamus- <strong>Tuberomammillary nucleus </strong>(TMN), releasing histamine.<ul><li>The wake-promoting area stimulates two important nuclei of the reticular activating system, i.e., <strong>Raphe nuclei (RN)</strong>, which produce <strong>serotonin</strong>, and <strong>Locus coeruleus (LC)</strong>, which produces <strong>norepinephrine</strong>.</li><li>These act at the level of the thalamus, from which all the diffuse projections will reach the cortex, and the active cortex means the person will remain awake.</li><li>This active cortex indefinitely produces metabolites with awakeness, <strong>primarily Adenosine</strong>.</li><li><strong>An increase in adenosine</strong> acts at the level of the basal forebrain and <strong>stimulates </strong>the sleep-promoting area.</li></ul></li><li><strong>Sleep-Promoting Area:</strong> Located in the anterior hypothalamus- <strong>Ventrolateral preoptic nucleus </strong>(VLPO), releasing GABA.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/RecallGTPII22072025/86E.png\">",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Expansion of right somatosensory fibres for the hand into neighbouring areas</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Neighbouring fibres of the right somatosensory area extending into the right-hand area</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Expansion of the right sensory cortex</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Expansion of the left sensory cortex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient experiences phantom limb pain following the amputation of the right limb. What would a PET scan most likely reveal in such a case?</span></p>",
      "unique_key": "Q314447",
      "question_audio": null,
      "question_video": null,
      "map_id": 314447,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li>After amputation, the brain undergoes cortical reorganisation.</li><li>In this case, the <strong>neighbouring somatosensory fibres</strong> that previously represented adjacent body parts extend into the region that formerly represented the right hand.</li><li>This reorganisation is associated with the perception of phantom limb pain.</li></ul><p><strong>Explanation for other options:</strong></p><p><strong>Expansion of right somatosensory fibres for the hand into Neighbouring areas (Option A):</strong></p><ul><li>Somatosensory fibres specifically responsible for the right hand expand into neighbouring regions.</li><li>However, it is not the fibres themselves that expand; rather, it is the cortical representation that changes.</li></ul><p><strong>Expansion of right sensory cortex (Option C):</strong></p><ul><li>Implies a general enlargement of the right sensory cortex.</li><li>However, the expansion is not global; rather, it involves the Neighbouring cortical areas invading the region corresponding to the amputated limb.</li></ul><p><strong>Expansion of left sensory cortex (Option D):</strong></p><ul><li>The left sensory cortex is responsible for processing sensory input from the right side of the body.</li><li>The reorganisation occurs in the sensory cortex corresponding to the amputated limb (in this case, the right cortex, which processes left-sided sensations).</li></ul><p><strong>Key Takeaway:</strong></p><p><strong>Phantom Limb Pain</strong></p><ul><li>Perceived due to cortical plasticity</li><li>In the phantom limb phenomenon, the limb does not exist (amputated), but the patient complains that he feels pain or itch in the limb.</li><li>Based on the evidence, brain reorganisation occurs when sensory input is cut off. For example, in leg amputees, the ventral posterior thalamic nucleus can perceive the signal that once received input from the leg and foot, now responds to stump (thigh) stimulation.n</li></ul><p><strong>Management :</strong></p><ol><li><strong>Epidural Anaesthesia: </strong>Used during amputation surgery to reduce acute pain and subsequent need for opioids, lowering phantom pain incidence<strong>.</strong></li><li><strong>Spinal Cord Stimulation: </strong>Electric current stimulates spinal pathways, reducing phantom limb pain and causing a tingling sensation insteadin the phantom limb</li></ol>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Surface tension - decreased; Compliance - increased</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Surface tension - increased; Compliance decreased</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Both surface tension and compliance decreased</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Both surface tension and compliance increased</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A preterm infant born at 28 weeks develops signs of respiratory distress syndrome. Which statement accurately describes the changes in surface tension and lung compliance in this condition?</span></p>",
      "unique_key": "Q314448",
      "question_audio": null,
      "question_video": null,
      "map_id": 314448,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>Surface tension increased and compliance decreased; </strong>this statement is accurate regarding surface tension and compliance in a preterm baby with<strong> respiratory distress syndrome (RDS).</strong></p><p>Elastic tissue recoil and surface tension are the two opposing forces to <strong>lung compliance, </strong>and are <strong>not opposing forces to each other.</strong></p><p>Two primary factors influence lung compliance:</p><ul><li><strong>Elastic forces of the lung tissue</strong>:<ul><li>These forces are primarily determined by the presence of elastin and collagen fibres within the lung parenchyma (the functional tissue of the lungs).</li><li>In a deflated lung, these fibres are contracted and kinked. As the lung expands during inspiration, these fibres stretch and unkink, generating an elastic force that opposes further expansion.</li></ul></li><li><strong>Surface tension</strong>:<ul><li>A thin layer of fluid lines the inside of the alveoli. At the air-fluid interface within the alveoli, surface tension arises from the stronger attraction between water molecules compared to the attraction between water molecules and air molecules.</li><li>This surface tension creates an inward pull, attempting to minimise the surface area of the fluid lining the alveoli. Consequently, this inward pull contributes to the elastic recoil of the lungs, making them tend to collapse.</li></ul></li></ul><p><strong>Reference:</strong></p><ol><li><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK538324/\" target=\"_blank\">Pulmonary Compliance - StatPearls - NCBI Bookshelf</a></li></ol>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Segment la is due to residual urine</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Segment Ib is due to Laplace law</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Micturition fails to happen in segment II</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Micturition occurs in segment Ib</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding the given cystometrogram?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizSep2025/PYQPhysioII29092025/7Q.png\"></span></p>",
      "unique_key": "Q314449",
      "question_audio": null,
      "question_video": null,
      "map_id": 314449,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Segment Ib is due to Laplace law where volume is increased but there is no rise in pressure,</p><p><strong>Cystometrogram Phases and Laplace's Law:</strong></p><p><strong>Phases of Cystometrogram:</strong></p><ul><li><strong>Initial (Filling) Phase</strong>:<ul><li>The bladder fills with sterile fluid.</li><li>Intra-vesical pressure (Pves) rises.</li><li>Detrusor muscle contracts, causing initial pressure increase without volume change.</li><li>Divided into three segments:<ul><li><strong>Phase I</strong>: Up to 1/3 of max capacity.</li><li><strong>Phase II</strong>: 1/3 to 2/3 of max capacity.</li><li><strong>Phase III</strong>: 2/3 to max capacity.</li></ul></li><li>Provides insights into detrusor properties, especially in neurogenic bladders.</li></ul></li><li><strong>Emptying Phase</strong>:<ul><li>Characterized by rhythmic external urethral sphincter contractions and increased Pves.</li><li>High-frequency pressure oscillations (HFPO) during active voiding.</li></ul></li><li><strong>Rebound Phase</strong>:<ul><li>Post-voiding, Pves increases as a rebound effect.</li><li>Indicates residual pressure changes after voiding.</li></ul></li></ul><p><strong>Application of Laplace's Law:</strong></p><ul><li><strong>Formula</strong>:<br /> P=2TrP = \\frac{2T}{r}P=r2T <br /> Where:<ul><li><strong>P</strong> = internal pressure</li><li><strong>T</strong> = wall tension</li><li><strong>r</strong> = radius</li></ul></li><li>As the bladder fills, its radius increases, influencing pressure and tension.</li><li>Helps interpret pressure changes during filling and voiding, especially in detrusor overactivity or compliance issues.</li></ul><p><strong>Clinical Relevance:</strong></p><ul><li>Key for diagnosing urological conditions:<ul><li>Overactive bladder (OAB)</li><li>Bladder outlet obstruction</li><li>Neurogenic bladder dysfunction</li></ul></li><li>Analyzing bladder pressure and compliance during each phase aids in personalized treatment strategies</li></ul><p><strong>Key Takeaways:</strong></p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizSep2025/PYQPhysioII29092025/7E.png\"><p><strong>Reference:</strong></p><p><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7814486/\" target=\"_blank\">https://pmc.ncbi.nlm.nih.gov/articles/PMC7814486/</a></p><p><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4092174/\" target=\"_blank\">https://pmc.ncbi.nlm.nih.gov/articles/PMC4092174/</a></p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">TRPP3</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">T2R</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">T1R3</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">T1R1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following receptors is primarily responsible for the perception of a sour taste?</span></p>",
      "unique_key": "Q314450",
      "question_audio": null,
      "question_video": null,
      "map_id": 314450,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>TRPP3 </strong>(transient receptor potential polycystin 3), also known as PKD2L1, is a cation channel that has been proposed to be involved in sour taste</p><ul><li>Humans have five established basic tastes: sweet, sour, bitter, salty, and umami.</li><li>All these tastes are recognised by <strong>binding of the taste chemical to a protein receptor molecule</strong> that lies on the<strong> taste receptor cell </strong>to initiate the receptor potential.</li><li>Each taste has a different mechanism for triggering receptor potential.</li></ul><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/RecallGTPI15072025/47E.png\">",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">SGLT 1</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">SGLT 2</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">GLUT 4</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Na-Ca transporter</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child with loose stools for one day presented to your OPD. On examination, signs of dehydration were present and the child was given ORS. It facilitates glucose absorption through which of the following receptors?</span></p>",
      "unique_key": "Q314451",
      "question_audio": null,
      "question_video": null,
      "map_id": 314451,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li>Sodium-Glucose Transporter 1 facilitates glucose absorption via sodium co-transport in the small intestine</li><li>This step is crucial for ORS effectiveness.</li></ul><p><strong>Glucose Transporters:</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizSep2025/PYQPhysioII29092025/9E.png\"><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Na-Ca transporter (Option D):</strong> Is involved in calcium homeostasis, not glucose absorption in the gut.</p>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Simple diffusion</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Facilitated diffusion</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary active transport</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary active transport</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What type of transport across the cell membrane is given below?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/PG2023Recall28072025/53Q.png\"></span></p>",
      "unique_key": "Q314452",
      "question_audio": null,
      "question_video": null,
      "map_id": 314452,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The image represents <strong>facilitated diffusion,</strong> a passive transport that moves substances <strong>down their concentration gradient without using cellular energy, </strong>but requires the assistance of specific carrier proteins embedded in the cell membrane.</p><p>This process is essential for transporting large or polar molecules that cannot cross the cell membrane's lipid bilayer by simple diffusion.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizJul2025/PG2023Recall28072025/53E.png\"><p><strong>Explanation for other options:</strong></p><p><strong>Primary active transport (Option C)</strong>: This active transport uses cellular energy (ATP) to transport substances against their concentration gradient. This process often involves specific carrier proteins, such as the Na+/K+ ATPase pump.</p><p><strong>Secondary active transport (Option D):</strong> This type of active transport uses the energy stored in the form of ion concentration gradients, established by primary active transport, to drive the transport of other substances against their concentration gradient.</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Shivering</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Vasoconstriction</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Sweating</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine secretion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What changes do not occur in stage A as compared to stage B when the hypothalamic thermostat in a patient is reset from point A to point C, as depicted below?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizSep2025/PYQPhysioII29092025/11Q.png\"></span></p>",
      "unique_key": "Q314453",
      "question_audio": null,
      "question_video": null,
      "map_id": 314453,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The graph shows <strong>\"Setting of thermostat\"</strong> (hypothalamic set point) and <strong>\"Actual body temperature\" </strong>over time.</p><ul><li><strong>Stage A</strong>: The set point is at a lower level (point A), then it's raised to a higher level (point C).</li><li><strong>Stage B</strong>: After the set point has been raised and the body is warming to meet it.</li></ul><p>Therefore:</p><ul><li><strong>Stage A</strong> = period when body temperature is below the new set point (the brain wants higher temperature).</li><li><strong>Stage B</strong> = period when body temperature is above the new set point (the brain wants lower temperature).</li></ul><p><strong>Physiological responses in each stage:</strong></p><p>When set point increases (start of Stage A):</p><ul><li>The body acts as if it's too cold relative to the new set point.</li><li>Mechanisms to <strong>conserve heat</strong> and <strong>generate heat</strong> are activated:<ul><li><strong>Vasoconstriction</strong> <strong>(Option B ruled out)</strong> of skin vessels &rarr; reduce heat loss.</li><li><strong>Shivering (Option A ruled out)</strong> &rarr; generate heat.</li><li><strong>Epinephrine secretion</strong> <strong>(Option C ruled out) </strong>&rarr; increase metabolic heat production.</li><li><strong>Behavioral changes</strong> (seeking warmth, etc.).</li></ul></li></ul><p>When set point is exceeded (Stage B):</p><ul><li>The body acts as if it's too warm relative to the set point.</li><li>Mechanisms to <strong>lose heat</strong> are activated:<ul><li><strong>Sweating</strong> &rarr; evaporative cooling.</li><li><strong>Vasodilation</strong> of skin vessels &rarr; increase heat loss.</li><li>Decreased metabolic heat production.</li></ul></li></ul><p><strong>Key Takeaways:</strong></p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizSep2025/PYQPhysioII29092025/11E.png\">",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Apo B-48 defect</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Apo B-100 defect</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Apo C-II defect</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">LDL receptor defect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents to the emergency room with severe abdominal pain, and serum triglyceride levels are 1500 mg/dL. What is the most likely defect present?</span></p>",
      "unique_key": "Q314454",
      "question_audio": null,
      "question_video": null,
      "map_id": 314454,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The patient's presentation of severe abdominal pain and elevated serum triglyceride levels suggests familial chylomicronaemia syndrome, and it is caused by an <strong>Apo-CII defect.</strong></p><p><strong>Type I Hyperlipoproteinemia (Familial Chylomicronemia Syndrome)</strong></p><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizSep2025/PYQPhysioII29092025/12E.png\"><p><strong>Explanation for other options:</strong></p><p><strong>Apo B-48 defect (Option A)</strong> is commonly associated with abetalipoproteinemia. Clinical features include fat malabsorption, Vitamin K deficiency, and Vitamin A deficiency symptoms.</p><p><strong>Apo B-100 defect (Option B)</strong> (Hypercholesterolemia) presents with atherosclerosis, coronary artery disease (early onset) and Tendon xanthomas.</p><p><strong>LDL receptor defect (Option D) </strong>(Hypercholesterolemia) presents with atherosclerosis, coronary artery disease (early onset) and Tendon xanthomas.</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Microglia</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Oligodendrocytes</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Astrocytes</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Ependymal cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which cells are impacted in multiple sclerosis?</span></p>",
      "unique_key": "Q314455",
      "question_audio": null,
      "question_video": null,
      "map_id": 314455,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li><strong>Multiple sclerosis (MS)</strong> primarily affects <strong>oligodendrocytes</strong>, which are responsible for producing and maintaining the myelin sheath in the central nervous system (CNS).</li><li>In MS, the immune system mistakenly attacks the myelin, leading to demyelination and impairing nerve signal transmission.</li></ul><p><strong>Multiple sclerosis (MS)</strong><br /> <br /> <strong>Definition</strong></p><ul><li>Chronic, immune-mediated demyelinating disease of the CNS marked by inflammation, demyelination, gliosis (scarring), and progressive neurodegeneration.</li></ul><p><strong>Causes &amp; Risk Factors</strong></p><ul><li><strong>Autoimmune dysregulation:</strong> Aberrant immune response against CNS myelin.</li><li><strong>Genetics:</strong> &uarr; risk with family history; HLA-DRB1 association.</li><li><strong>Environmental:</strong> Low vitamin D, smoking, prior Epstein&ndash;Barr virus (EBV) infection.</li><li><strong>Geography:</strong> Higher prevalence farther from the equator.</li></ul><p><strong>Pathophysiology</strong></p><ul><li><strong>Activation:</strong> Peripheral T-cells activate and cross the blood&ndash;brain barrier.</li><li><strong>Inflammation:</strong> Recognition of myelin antigens &rarr; inflammatory cascade (B-cells, macrophages).</li><li><strong>Demyelination:</strong> Immune attack destroys oligodendrocyte-produced myelin.</li><li><strong>Plaques:</strong> Demyelinated areas form MRI lesions (&ldquo;plaques&rdquo;) disseminated in time and space.</li><li><strong>Axonal injury:</strong> Impaired conduction &rarr; axonal transection/degeneration &rarr; permanent disability.</li></ul><p><strong>Clinical Features</strong></p><ul><li><strong>Sensory:</strong> Numbness, paresthesias, Lhermitte sign (electric shock with neck flexion).</li><li><strong>Motor:</strong> Weakness, spasticity, gait difficulty.</li><li><strong>Cerebellar:</strong> Ataxia, intention tremor, dysarthria.</li><li><strong>Visual:</strong> Optic neuritis (painful unilateral vision loss), diplopia.</li><li><strong>Bowel/Bladder:</strong> Urgency, retention, incontinence, constipation.</li><li><strong>Other:</strong> Fatigue, cognitive slowing/memory issues, depression, heat intolerance (Uhthoff phenomenon).</li></ul><p><strong>Disease Courses</strong></p><ul><li><strong>Relapsing&ndash;Remitting MS (RRMS):</strong> ~85% at onset; discrete attacks with partial/complete recovery.</li><li><strong>Secondary Progressive MS (SPMS):</strong> Gradual worsening after RRMS, &plusmn; superimposed relapses.</li><li><strong>Primary Progressive MS (PPMS):</strong> Steady progression from onset without clear relapses.</li></ul><p><strong>Management</strong></p><ul><li><strong>Acute relapse</strong><ul><li>High-dose corticosteroids (e.g., IV methylprednisolone) to reduce inflammation and shorten relapse.</li></ul></li><li><strong>Disease-modifying therapies (DMTs)</strong> - reduce relapse rate and delay disability:<ul><li><strong>Platform/injectables:</strong> Interferon-&beta;, glatiramer acetate.</li><li><strong>Oral agents:</strong> Fingolimod, dimethyl fumarate, teriflunomide.</li><li><strong>Monoclonal antibodies (high-efficacy):</strong> Natalizumab (use in JCV-negative), ocrelizumab (RRMS &amp; PPMS), alemtuzumab.</li></ul></li><li><strong>Symptomatic management</strong><ul><li><strong>Spasticity:</strong> Baclofen, tizanidine.</li><li><strong>Fatigue:</strong> Amantadine, modafinil.</li><li><strong>Bladder/Bowel:</strong> Anticholinergics, scheduled voiding.</li><li><strong>Pain:</strong> Neuropathic agents (gabapentin, pregabalin).</li></ul></li><li><strong>Rehabilitation &amp; support</strong><ul><li>Physical therapy, occupational therapy, speech therapy, psychological support.</li></ul></li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizSep2025/PYQPhysioII29092025/13E1.png\"><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Microglia (Option A)</strong> are the resident immune cells of the CNS, and while they may be involved in the immune response in MS, they are not the primary targets.</p><p><strong>Astrocytes (Option C)</strong> support neurons and maintain the blood-brain barrier, and while they may be reactive in MS, they are not directly impacted in the disease.</p><p><strong>Ependymal cells (Option D)</strong> line the ventricles of the brain and produce cerebrospinal fluid, which are not directly involved in MS pathology.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Subthalamic nuclei</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Substantia nigra</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Putamen</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudate nucleus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a patient who experienced a stroke 2 days ago, the current symptoms include uncontrollable, forceful, and jerking motions of the limbs on one side. Where is the probable location of the lesion in this individual?</span></p>",
      "unique_key": "Q314456",
      "question_audio": null,
      "question_video": null,
      "map_id": 314456,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li>The patient's presentation of uncontrollable, forceful, jerking movements on one side of the body, coupled with a history of stroke, is characteristic of <strong>hemiballismus</strong>.</li><li>This movement disorder is defined by <strong>involuntary, violent flinging motions of the ipsilateral limbs.</strong></li></ul><p><strong>Hyperkinetic Diseases:</strong></p><ul><li><strong>Hemiballismus:</strong><ul><li>Damage to the subthalamic nucleus, leading to decreased inhibition of the thalamus and excessive movement.</li></ul></li><li><strong>Huntington's Disease:</strong><ul><li>Degeneration of the indirect pathway in the striatum, causing involuntary movements similar to hemiballismus.</li></ul></li><li><strong>Dystonia:</strong><ul><li>Dysfunction in the direct pathway, resulting in sustained, twisting movements.&nbsp;</li></ul></li></ul><p><strong>Hypokinetic Diseases</strong></p><ul><li><strong>Parkinsonism:</strong><ul><li>Cause: Reduced dopamine in the substantia nigra.</li><li>Symptoms: Akinesia, bradykinesia, cogwheel rigidity, resting tremor, shuffling gait, stooped posture, reduced facial expression, small handwriting, and mood/cognitive issues.</li></ul></li></ul><p><strong>Basal Ganglia:</strong></p><ul><li>The basal ganglia are a group of <strong>subcortical nuclei </strong>in the brain involved in regulating movement and coordinating motor activity.</li><li>Key parts include:<ul><li><strong>Striatum</strong>:<ul><li>Consists of the caudate nucleus and putamen.</li><li>It's the main input center for the basal ganglia, receiving information from the cerebral cortex. <strong>(Options C &amp; D ruled out)</strong></li></ul></li><li><strong>Globus Pallidus</strong>:<ul><li>Divided into the external (GPe) and internal (GPi) segments.</li><li>It plays a role in the regulation of voluntary movement by processing signals from the striatum.</li></ul></li><li><strong>Substantia Nigra</strong>:<ul><li>Located in the midbrain and has two parts: the pars compacta (which produces dopamine) and the pars reticulata.</li><li>It is involved in movement control and has a key role in the dopamine system. <strong>(Option B ruled out)</strong></li></ul></li><li><strong>Subthalamic Nucleus</strong>:<ul><li>Located below the thalamus, it contributes to motor control by influencing the output of the globus pallidus.</li></ul></li></ul></li></ul>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenylyl cyclase</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Guanylyl cyclase</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Phospholipase C</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Phospholipase A2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Beta 2 receptor action leading to hyperglycemia/hypoglycemia is mediated by which of the following enzymes?</span></p>",
      "unique_key": "Q314457",
      "question_audio": null,
      "question_video": null,
      "map_id": 314457,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000001
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li>Adenylyl cyclase mediates &beta;2-adrenergic receptor action by increasing cAMP, which activates PKA.</li><li>This primarily drives hepatic glycogenolysis and gluconeogenesis, resulting in <strong>hyperglycemia</strong>.</li></ul><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizSep2025/PYQPhysioII29092025/15E.png\"><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizSep2025/PYQPhysioII29092025/15E1.png\"><p><strong>Acute &beta;2-AR Stimulation:</strong> Elevates blood glucose via hepatic glucose release and insulin secretion.</p><p><strong>Chronic &beta;2-AR Stimulation: </strong>Lowers glucose by enhancing GLUT4-mediated uptake in muscle.</p><p><strong>Counterregulatory Role: </strong>Maintains glucose homeostasis during stress or fasting.</p><p><strong>Explanation for Incorrect options:</strong></p><p><strong>Guanylyl cyclase (Option B):</strong> Primarily involved in cGMP signaling, unrelated to &beta;2-adrenergic receptor-mediated glucose metabolism.</p><p><strong>Phospholipase C (Option C): </strong>Activates in Gq-coupled receptor pathways, not associated with &beta;2-adrenergic receptor signaling for glucose regulation.</p><p><strong>Phospholipase A2 (Option D):</strong> Involved in arachidonic acid metabolism, unrelated to glucose homeostasis or &beta;2-adrenergic receptor pathways.</p>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}